WELLBIOTEC CO.,LTD Logo

WELLBIOTEC CO.,LTD

A diversified company in biopharma, EV charging, logistics, and leather products.

010600 | KO

Overview

Corporate Details

ISIN(s):
KR7010600005
LEI:
Country:
South Korea
Address:
서울특별시 강남구 영동대로106길 17 5층, 강남구

Description

WELLBIOTEC CO.,LTD. is a diversified company with operations in several sectors. Its business activities include the development and distribution of biopharmaceutical products, such as specialized medicines, health functional foods, and diagnostic kits. The company is also involved in the electric vehicle (EV) charging business and logistics. Additionally, it manufactures and sells leather products for fashion goods, including shoes and handbags.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2022-08-26 00:00
[기재정정]주요사항보고서(전환사채권발행결정)
Korean HTML 55.0 KB
2022-08-16 00:00
반기보고서 (2022.06)
Korean HTML 1.7 MB
2022-08-11 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 78.0 KB
2022-07-29 00:00
[기재정정]주요사항보고서(유상증자결정)
Korean HTML 27.7 KB
2022-06-22 00:00
유상증자또는주식관련사채등의발행결과(자율공시)
Korean HTML 5.5 KB
2022-06-21 00:00
[기재정정]타법인주식및출자증권처분결정
Korean HTML 19.0 KB
2022-06-21 00:00
주요사항보고서(전환사채권발행결정)
Korean HTML 39.2 KB
2022-05-27 00:00
[기재정정]주요사항보고서(전환사채권발행결정)
Korean HTML 58.2 KB
2022-05-17 00:00
단일판매ㆍ공급계약체결
Korean HTML 7.9 KB
2022-05-13 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 78.5 KB
2022-05-12 00:00
분기보고서 (2022.03)
Korean HTML 1.6 MB
2022-05-10 00:00
주식등의대량보유상황보고서(약식)
Korean HTML 82.6 KB
2022-04-22 00:00
[기재정정]주요사항보고서(전환사채권발행결정)
Korean HTML 56.2 KB
2022-03-30 00:00
정기주주총회결과
Korean HTML 22.2 KB
2022-03-30 00:00
주식매수선택권부여에관한신고
Korean HTML 12.9 KB

Automate Your Workflow. Get a real-time feed of all WELLBIOTEC CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for WELLBIOTEC CO.,LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for WELLBIOTEC CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.